TerminatedPhase 1NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
Studying Adenoid cystic carcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Poseida Therapeutics, Inc.
- Principal Investigator
- Rajesh Belani, M.D.Sponsor Executive Medical Director
- Intervention
- P-PSMA-101 CAR-T cells(biological)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2024
Study locations (10)
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- University of California San Diego, San Diego, California, United States
- University of California San Francisco, San Francisco, California, United States
- Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
- Tulane University Hospital and Clinic, New Orleans, Louisiana, United States
- University of Maryland, Baltimore, Baltimore, Maryland, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Tennessee Oncology, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04249947 on ClinicalTrials.govOther trials for Adenoid cystic carcinoma of the cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07507578A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic CarcinomaFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT06781567Clinical Trial of HG146 Administered to Participants with Adenoid Cystic CarcinomaHitGen Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT04209660Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland CancersMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE2NCT04214366Adenoid Cystic Carcinoma and Carbon Ion Only IrradiationHeidelberg University
- RECRUITINGPHASE1, PHASE2NCT03556228VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLC
See all trials for Adenoid cystic carcinoma of the cervix uteri →